Olmesartan
- TRADE NAMES: Benicar (Sankyo); Olmetec (Daiichi Sankyo)
- INDICATIONS: Hypertension
- CLASS: Angiotensin receptor antagonist (blocker), Antihypertensive
- HALF-LIFE: ~13 hours
ACE inhibitors, Adrenergic neurone blockers, Aldesleukin, Aliskiren, Alprostadil, Amifostine, Antihypertensives, Antipsychotics, Anxiolytics and hypnotics, Baclofen, Beta blockers, Calcium channel blockers, Clonidine, Colesevelam, Corticosteroids, Cyclosporine, Diazoxide, Diuretics, Eltrombopag, Eplerenone, Estrogens, General anesthetics, Heparins, Hydralazine, Levodopa, Lithium, MAO inhibitors, Methyldopa, Methylphenidate, Minoxidil, Moxisylyte, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Pentoxifylline, Phosphodiesterase 5 inhibitors, Potassium salts, Quinine, Rituximab, Tacrolimus, Tizanidine, Tolvaptan, Trimethoprim
PREGNANCY CATEGORY: D
category C in first trimester; category D in second and third trimesters
Contra-indicated in patients with diabetes.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 03/26/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric